Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fuji
Covington
Baxter
Federal Trade Commission
AstraZeneca
Queensland Health
Colorcon
Chubb
Boehringer Ingelheim

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,366,145

« Back to Dashboard

Summary for Patent: 4,366,145

Title: Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
Abstract:A stable ergot alkaloid soft gelatin capsule consisting essentially of a soft gelatin capsule shell and encapsulated therein a liquid center fill solution consisting essentially of a therapeutically effective amount of an ergot alkaloid of the formula ##STR1## wherein R.sub.1 is hydrogen or halogen, R.sub.2 is hydrogen or C.sub.1-4 alkyl, R.sub.3 is isopropyl, sec.-butyl, isobutyl or benzyl, R.sub.4 is methyl, ethyl or isopropyl, and either R.sub.5 is hydrogen and R.sub.6 is hydrogen or methoxy or R.sub.5 and R.sub.6 together is an additional bond, or mixtures thereof, dissolved in a pharmaceutically acceptable polar, hydrophilic soft gelatin capsule center fill solvent.
Inventor(s): Stoopak; Samuel B. (West Caldwell, NJ), Kornblum; Saul S. (Springfield, NJ), Jacobs; Allen L. (Randolph, NJ)
Assignee: Sandoz, Inc. (East Hanover, NJ)
Application Number:06/277,980
Patent Claim Types:
see list of patent claims
Use; Dosage form; Formulation;

No matches for this query

International Patent Family for Patent: 4,366,145

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
France2508313► Subscribe
Finland80591► Subscribe
Spain8402504► Subscribe
Finland822187► Subscribe
Spain513359► Subscribe
Denmark280282► Subscribe
Germany3222250► Subscribe
Cyprus1430► Subscribe
Switzerland655848► Subscribe
Canada1191788► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Merck
McKesson
Covington
Express Scripts
Accenture
Fish and Richardson
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot